ERBB2 and breast carcinoma: Given our finding that co-activation of HER2 and HER3 induces IL8 production, we compared IL8 expression levels in BT474 cells, a HER2- and HER3-positive breast cancer cell line, to MCF10A cells expressing an empty vector, HER2, HER3 or HER2/3.